Abstract:Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Eurostars - Heartpace 114245 Background Electronic pacemakers have several important shortcomings which are difficult to overcome due to their hardware-based design. Gene therapy-based biological pacemakers may provide a different platform which can overcome these limitations. Such biological pacemaker strategies center around overexpression of the pacemaker ion channel HCN2, either alone or with other transgenes to potentiate pacemaker performance, such as the skeletal muscle sodium channel SkM1. In order to develop clinically applicable pacemaker gene therapies further engineering is needed, which would benefit from a reliable small animal model. At present it is unknown if the rat AV block model can be used to evaluate ion channel-based biological pacing. Aim In the present study, we aim to validate a modified rat AV-block model for the evaluation of HCN2 and SKM1-based biological pacing. Methods AV-block was generated in female rats by epicardially applied needle ablation of the AV-nodal region, as previously described (N.K. ). Complete AV-block was confirmed 7 days post-ablation by loss of P-wave and QRS-complex association on the body surface ECG. Seven days post-ablation, 3 groups of animals were injected into the left ventricular apex with Ad5-TNNT2-HCN2, Ad5-TNNT2-SkM1 or saline (control). 14 days post-ablation, ECG analysis was performed during anesthesia under baseline and after i.v. administration of isoprenaline. Upon completion of functional testing, tissue samples were harvested followed by gene expression analysis using qPCR. Results Injection of Ad5-TNNT2-HCN2, Ad5-TNNT2-SkM1 or saline did not result in ectopic activation patterns in baseline conditions 7 days after injection. Administration of isoprenaline results in reversal of the QRS complexes 90% of total measurement time in Ad5-TNNT2-HCN2 injected animals. Saline and Ad5-TNNT2-SkM1 showed no change in activation pattern upon isoprenaline administration. Gene expression analysis revealed expression of HCN2 in the injection site following Ad5-TNNT2-HCN2 injection, with minimal spread to non-target regions. However, this analysis also showed Ad5-TNNT2-SkM1 did not express well in this context. Conclusion Our modified rat AV-block model, when administered with isoprenaline, recapitulated expected biological pacemaker activity of HCN2 gene delivery. However, lack of effective expression of SkM1 renders direct comparison of these relevant transgenes difficult. Nevertheless, we expect this rat AV-block model can provide a valuable tool for the evaluation of novel ion channel-based biological pacemaker strategies.

Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18

Transplanted Neonatal Cardiomyocytes As A Potential Biological Pacemaker in Pigs with Complete Atrioventricular Block

TBX18 Gene Induces Adipose-Derived Stem Cells to Differentiate into Pacemaker-Like Cells in the Myocardial Microenvironment.

Adenoviral Gene Transfer of HCN4 Creates a Genetic Pacemaker in Pigs with Complete Atrioventricular Block

[Transfecting Rat Heart with Human Pacemaker Gene in Vivo to Create a Biological Pacemaker].

HCN2-based biological pacing in a modified rat AV-block model

Biological pacemaker created by fetal cardiomyocyte transplantation

Toward Biological Pacing by Cellular Delivery of Hcn2/SkM1

Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18

Overexpression of the Medium‑conductance Calcium‑activated Potassium Channel (SK4) and the HCN2 Channel to Generate a Biological Pacemaker

Induced Pacemaker Cells Created By In Vivo Somatic Reprogramming: Phenotypic Comparison With Native Sinoatrial Node Cells

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Transcription Factor Tbx18 Promotes Adult Rat Bone Mesenchymal Stem Cell Differentiation To Biological Pacemaker Cells

Abstract 11471: Engineered Bacterial Sodium Channel Gene Therapy Prevents Contractile Deficit and Reduces Ventricular Arrhythmias in a Non-Human Primate Model of Myocardial Infarction

Invitro Study of the Effects of Reprogramming Neonatal Rat Fibroblasts Transfected with TBX18 on Spontaneous Beating in Neonatal Rat Cardiomyocytes

Stem cell-derived cardiomyocytes expressing a dominant negative pacemaker HCN4 channel do not reduce the risk of graft-related arrhythmias

Thermogenetics for cardiac pacing

AAV-mediated gene delivery to the cardiac conduction system

A New Combination of Transcription Factors Increases the Harvesting Efficiency of Pacemaker‑like Cells.

Induced Pluripotent Stem Cell-Based Treatment Of Acquired Heart Block: The Battle For Tomorrow Has Begun!

Wireless, Battery-Free, Fully Implantable Multimodal and Multisite Pacemakers for Applications in Small Animal Models